BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16145369)

  • 1. T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas.
    Bonsib SM
    J Urol; 2005 Oct; 174(4 Pt 1):1199-202; discussion 1202. PubMed ID: 16145369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas.
    Bonsib SM
    Am J Surg Pathol; 2004 Dec; 28(12):1594-600. PubMed ID: 15577678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal sinus involvement in renal cell carcinomas.
    Bonsib SM; Gibson D; Mhoon M; Greene GF
    Am J Surg Pathol; 2000 Mar; 24(3):451-8. PubMed ID: 10716160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological staging of renal cell carcinoma: a review of 300 consecutive cases with emphasis on retrograde venous invasion.
    Taneja K; Arora S; Rogers CG; Gupta NS; Williamson SR
    Histopathology; 2018 Oct; 73(4):681-691. PubMed ID: 29897139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system.
    Gettman MT; Blute ML; Spotts B; Bryant SC; Zincke H
    Cancer; 2001 Jan; 91(2):354-61. PubMed ID: 11180082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma invading the urinary collecting system: implications for staging.
    Uzzo RG; Cherullo E; Myles J; Novick AC
    J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal veins and venous extension in clear cell renal cell carcinoma.
    Bonsib SM
    Mod Pathol; 2007 Jan; 20(1):44-53. PubMed ID: 17170742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage T3a renal cell carcinoma: staging accuracy of CT for sinus fat, perinephric fat or renal vein invasion.
    Sokhi HK; Mok WY; Patel U
    Br J Radiol; 2015 Jan; 88(1045):20140504. PubMed ID: 25410425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrograde venous invasion in renal cell carcinoma: a complication of sinus vein and main renal vein invasion.
    Bonsib SM; Bhalodia A
    Mod Pathol; 2011 Dec; 24(12):1578-85. PubMed ID: 21822202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma.
    Chen K; Lee BL; Huang HH; Tan BY; Lee LS; Ng LG; Lau W; Yuen JS
    Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New cut-off point between T1 and T2 renal cell carcinoma - necessary for a better discriminatory power of the TNM classification.
    Wunderlich H; Dreihaupt M; Schlichter A; Kosmehl H; Reichelt O; Schubert J
    Urol Int; 2004; 72(2):123-8. PubMed ID: 14963352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients?
    Gofrit ON; Shapiro A; Pizov G; Landau EH; Katz R; Zorn KC; Pode D
    J Urol; 2007 May; 177(5):1682-6. PubMed ID: 17437782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent.
    Gilbert SM; Murphy AM; Katz AE; Goluboff ET; Sawczuk IS; Olsson CA; Benson MC; McKiernan JM
    Urology; 2006 Aug; 68(2):287-91. PubMed ID: 16904438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hilar location is an independent prognostic factor for recurrence in T1 renal cell carcinoma after nephrectomy.
    Shim M; Song C; Park S; Kim A; Choi SK; Kim CS; Ahn H
    Ann Surg Oncol; 2015 Jan; 22(1):344-50. PubMed ID: 25323469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters.
    Delahunt B; Kittelson JM; McCredie MR; Reeve AE; Stewart JH; Bilous AM
    Cancer; 2002 Feb; 94(3):658-64. PubMed ID: 11857297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging of renal cell carcinoma: current progress and potential advances.
    Delahunt B; Eble JN; Samaratunga H; Thunders M; Yaxley JW; Egevad L
    Pathology; 2021 Jan; 53(1):120-128. PubMed ID: 33121821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
    Jacob JM; Williamson SR; Gondim DD; Leese JA; Terry C; Grignon DJ; Boris RS
    Urology; 2015 Nov; 86(5):956-61. PubMed ID: 26126697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.